I stumbled across a good link to a Continuing Education Program that really summarizes many of the points from this case: http://www.ashpmedia.org/symposia/afib/overview.html
Only a couple of points I want to make. First, the program is sponsored by Sanofi-Aventis. You should consider this since this drug company has a stake in this disease category. Hint: do you know what Multaq is?
Also, there is a "Supplement Issue" of the Journal of Managed Care Pharmacy about A-Fib:
http://www.ashpadvantage.com/website_images/pdf/jmcp_08012009.pdf It is important to rember that this is a supplement edition. Do you know why that is so important?
No comments:
Post a Comment